Current status of application of the secondary cytoreductive surgery for patients with epithelial ovarian carcinomas / 대한산부인과학회지

Recurrent ovarian cancer has been considered as a difficult disease to treat despite the rapid development of various chemotherapeutic agents and surgical techniques for several decades. Many investigators tried to establish the optimal triage for treat recurrent or persistent disease applying not only salvage regimen but also debulking surgery. We reviewed many literature concerning the surgical approaches for patients with primary treatment failure to outline the treatment scheme. Most of authors agrees that optimal or even maximal cytoreduction enables survival benefit of patients with refractory disease while the biologic characteristics of tumor may not affect the prognosis.